Review of S100A9 biology and its role in cancer

被引:154
|
作者
Markowitz, Joseph [1 ]
Carson, William E., III [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2013年 / 1835卷 / 01期
关键词
S100A9; Calgranulin B; Cancer; MRP-14; CALCIUM-BINDING PROTEINS; INVASIVE DUCTAL CARCINOMA; HIGH-GRADE DYSPLASIA; NORMAL COLON MUCOSA; FACTOR-KAPPA-B; GENE-EXPRESSION; SUPPRESSOR-CELLS; ARACHIDONIC-ACID; PROTEOMIC IDENTIFICATION; DIFFERENTIAL EXPRESSION;
D O I
10.1016/j.bbcan.2012.10.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
S100A9 is a calcium binding protein with multiple ligands and post-translation modifications that is involved in inflammatory events and the initial development of the cancer cell through to the development of metastatic disease. This review has a threefold purpose: 1) describe the S100A9 structural elements important for its biological activity, 2) describe the S100A9 biology in the context of the immune system, and 3) illustrate the role of S100A9 in the development of malignancy via interactions with the immune system and other cellular processes. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:100 / 109
页数:10
相关论文
共 50 条
  • [1] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [2] S100A8 and S100A9 in Cardiovascular Biology and Disease
    Averill, Michelle M.
    Kerkhoff, Claus
    Bornfeldt, Karin E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 223 - 229
  • [3] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631
  • [4] The Role of S100a9 in the Pathogenesis of Alzheimer's Disease: The Therapeutic Effects of S100a9 Knockdown or Knockout
    Chang, Keun-A
    Kim, Hee Jin
    Suh, Yoo-Hun
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 27 - 29
  • [5] S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
    Leanderson, Tomas
    Liberg, David
    Ivars, Fredrik
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2015, 15 (02) : 97 - 104
  • [6] S100A9 has a protective role in inflammation-induced skin carcinogenesis
    McNeill, Eileen
    Hogg, Nancy
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (04) : 798 - 808
  • [7] Significance of S100A8, S100A9 and calprotectin levels in bladder cancer
    Yasar, O.
    Akcay, T.
    Obek, C.
    Turegun, F. A.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2017, 77 (06) : 437 - 441
  • [8] Identification of S100A8 and S100A9 as Serological Markers for Colorectal Cancer
    Kim, Hye-Jung
    Kang, Hyun Ju
    Lee, Hanna
    Lee, Seung-Taek
    Yu, Myeong-Hee
    Kim, Hoguen
    Lee, Cheoju
    JOURNAL OF PROTEOME RESEARCH, 2009, 8 (03) : 1368 - 1379
  • [9] S100A8 and S100A9: New Insights into Their Roles in Malignancy
    Srikrishna, Geetha
    JOURNAL OF INNATE IMMUNITY, 2012, 4 (01) : 31 - 40
  • [10] Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
    Shabani, Fatemeh
    Farasat, Alireza
    Mahdavi, Majid
    Gheibi, Nematollah
    INFLAMMATION RESEARCH, 2018, 67 (10) : 801 - 812